Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0H6CA
|
||||
| Former ID |
DIB003324
|
||||
| Drug Name |
Lenercept
|
||||
| Synonyms |
Tenefuse; RsTNFR-IgG1; Ro-45-2081; TNF receptor-Ig, Roche; TNFR-IgG1 fusion protein, Roche
|
||||
| Indication | Asthma [ICD10:J45] | Discontinued in Phase 3 | [1] | ||
| Company |
Roche Holding AG
|
||||
| CAS Number |
CAS 156679-34-4
|
||||
| Target and Pathway | |||||
| Target(s) | TNF receptor | Target Info | Modulator | ||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004745) | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.